NIH, National Cancer Institute, Division of Cancer Treatment and Diagnosis (DCTD) NIH - National Institutes of Health National Cancer Institute DCTD - Division of Cancer Treatment and Diagnosis

Blood collection techniques, heparin and quinidine protein binding.

Author(s): Kessler KM, Leech RC, Spann JF

Publication: Clin Pharmacol Ther, 1979, Vol. 25, Page 204-10

PubMed ID: 759074 PubMed Review Paper? No

Purpose of Paper

The purpose of this paper was to determine the effects of collection and storage container, patient condition and heparin administration on the percentage of unbound quinidine in blood.

Conclusion of Paper

Blood collected into or stored in red or green stoppered Vacutainer tubes had higher concentrations of quinidine then blood collected and stored in all glass systems. Patient condition had no effect on quinidine concentration, but heparin administration, as occurs during cardiac catheterization, increased the percentage of unbound quinidine.

Studies

  1. Study Purpose

    The purpose of this study was to determine the effects of collection and storage container, heparin sulfate administration and collection method on the percentage of unbound quinidine in blood from healthy subjects and patients with congestive heart failure, chronic renal failure, or a cardiac catheter. Blood was stored for 24 h at 4 degrees C prior to analysis.

    Summary of Findings:

    Blood collected into or stored in red or green stoppered Vacutainer tubes for 24 h at 4 degrees C had higher concentrations of quinidine then blood collected and stored in all glass systems. There was a similar fraction of unbound quinidine in healthy control subjects and patients with congestive heart failure or chronic renal failure, but the fraction of unbound quinidine increased (p<0.0001) during cardiac catheterization. The elevation of quinidine during cardiac catheterization occurred simultaneously with heparin administration and was found both when the specimen was collected by venipuncture or through the catheter.

    Biospecimens
    Preservative Types
    • None (Fresh)
    Diagnoses:
    • Cardiovascular Disease
    • Normal
    • Other diagnoses
    Platform:
    AnalyteTechnology Platform
    Small molecule Fluorometry
    Pre-analytical Factors:
    ClassificationPre-analytical FactorValue(s)
    Biospecimen Acquisition Type of collection container/solution Glass syringe
    Green-stoppered Vacutainer
    Red-stoppered Vacutainer
    Preaquisition Diagnosis/ patient condition Normal volunteer
    Congestive heart failure
    Chronic renal failure
    Storage Type of storage container Glass-stoppered tube
    Red-stoppered tube
    Green-stoppered tube
    Biospecimen Acquisition Method of fluid acquisition Cardiac catheter
    Venipuncture
    Biospecimen Acquisition Time of biospecimen collection Prior to heparin
    At time of heparin injection
    After cardiac catheterization/heparin injection
    Biospecimen Acquisition Anatomical location of blood draw Peripheral vein
    Heart

You Recently Viewed  

News and Announcements

  • Most Downloaded SOPs in 2024

  • New Articles on the GTEx Project are Now FREELY Available!

  • Just Published!

  • More...